Artículos de revistas sobre el tema "MMV Malaria Box"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 31 mejores artículos de revistas para su investigación sobre el tema "MMV Malaria Box".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Müller, Joachim, Pablo A. Winzer, Kirandeep Samby y Andrew Hemphill. "In Vitro Activities of MMV Malaria Box Compounds against the Apicomplexan Parasite Neospora caninum, the Causative Agent of Neosporosis in Animals". Molecules 25, n.º 6 (24 de marzo de 2020): 1460. http://dx.doi.org/10.3390/molecules25061460.
Texto completoAllman, Erik L., Heather J. Painter, Jasmeet Samra, Manuela Carrasquilla y Manuel Llinás. "Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways". Antimicrobial Agents and Chemotherapy 60, n.º 11 (29 de agosto de 2016): 6635–49. http://dx.doi.org/10.1128/aac.01224-16.
Texto completoFong, Kim Y., Rebecca D. Sandlin y David W. Wright. "Identification of β-hematin inhibitors in the MMV Malaria Box". International Journal for Parasitology: Drugs and Drug Resistance 5, n.º 3 (diciembre de 2015): 84–91. http://dx.doi.org/10.1016/j.ijpddr.2015.05.003.
Texto completoWu, Wesley, Zachary Herrera, Danny Ebert, Katie Baska, Seok H. Cho, Joseph L. DeRisi y Ellen Yeh. "A Chemical Rescue Screen Identifies a Plasmodium falciparum Apicoplast Inhibitor Targeting MEP Isoprenoid Precursor Biosynthesis". Antimicrobial Agents and Chemotherapy 59, n.º 1 (3 de noviembre de 2014): 356–64. http://dx.doi.org/10.1128/aac.03342-14.
Texto completoLópez-Arencibia, Atteneri, Ines Sifaoui, María Reyes-Batlle, Carlos J. Bethencourt-Estrella, Desirée San Nicolás-Hernández, Jacob Lorenzo-Morales y José E. Piñero. "Discovery of New Chemical Tools against Leishmania amazonensis via the MMV Pathogen Box". Pharmaceuticals 14, n.º 12 (24 de noviembre de 2021): 1219. http://dx.doi.org/10.3390/ph14121219.
Texto completoAlemán Resto, Yesmalie y José A. Fernández Robledo. "Identification of MMV Malaria Box Inhibitors of Perkinsus marinus Using an ATP-Based Bioluminescence Assay". PLoS ONE 9, n.º 10 (22 de octubre de 2014): e111051. http://dx.doi.org/10.1371/journal.pone.0111051.
Texto completoMann, Lea, Markus Lang, Philipp Schulze, Jan Henrik Halz, René Csuk, Sophie Hoenke, Rüdiger W. Seidel y Adrian Richter. "Racemization-free synthesis of Nα-2-thiophenoyl-phenylalanine-2-morpholinoanilide enantiomers and their antimycobacterial activity". Amino Acids 53, n.º 8 (14 de julio de 2021): 1187–96. http://dx.doi.org/10.1007/s00726-021-03044-1.
Texto completoRuecker, A., D. K. Mathias, U. Straschil, T. S. Churcher, R. R. Dinglasan, D. Leroy, R. E. Sinden y M. J. Delves. "A Male and Female Gametocyte Functional Viability Assay To Identify Biologically Relevant Malaria Transmission-Blocking Drugs". Antimicrobial Agents and Chemotherapy 58, n.º 12 (29 de septiembre de 2014): 7292–302. http://dx.doi.org/10.1128/aac.03666-14.
Texto completoHostettler, Isabel, Joachim Müller y Andrew Hemphill. "In VitroScreening of the Open-Source Medicines for Malaria Venture Malaria Box Reveals Novel Compounds with Profound Activities against Theileria annulata Schizonts". Antimicrobial Agents and Chemotherapy 60, n.º 6 (14 de marzo de 2016): 3301–8. http://dx.doi.org/10.1128/aac.02801-15.
Texto completoBoyom, Fabrice F., Patrick V. T. Fokou, Lauve R. Y. Tchokouaha, Thomas Spangenberg, Alvine N. Mfopa, Ruffin M. T. Kouipou, Cedric J. Mbouna, Valerie F. Donkeng Donfack y Paul H. A. Zollo. "Repurposing the Open Access Malaria Box To Discover Potent Inhibitors of Toxoplasma gondii and Entamoeba histolytica". Antimicrobial Agents and Chemotherapy 58, n.º 10 (21 de julio de 2014): 5848–54. http://dx.doi.org/10.1128/aac.02541-14.
Texto completoKenneth Obiakor, Onyeka Chinwuba Obidiegwu, Keziah Uchechi Ajah, Christian Chidebe, Ajuzie Henry Ogechi y Ikemefuna Chijioke Uzochukwu. "Discovery of antiadhesins of Helicobacter pylori from existing drugs and medicines for malaria ventures pathogen box compounds". GSC Biological and Pharmaceutical Sciences 20, n.º 3 (30 de septiembre de 2022): 198–212. http://dx.doi.org/10.30574/gscbps.2022.20.3.0356.
Texto completoLucantoni, Leonardo, Sandra Duffy, Sophie H. Adjalley, David A. Fidock y Vicky M. Avery. "Identification of MMV Malaria Box Inhibitors of Plasmodium falciparum Early-Stage Gametocytes Using a Luciferase-Based High-Throughput Assay". Antimicrobial Agents and Chemotherapy 57, n.º 12 (23 de septiembre de 2013): 6050–62. http://dx.doi.org/10.1128/aac.00870-13.
Texto completoBuckingham, Steven D., Frederick A. Partridge, Beth C. Poulton, Benjamin S. Miller, Rachel A. McKendry, Gareth J. Lycett y David B. Sattelle. "Automated phenotyping of mosquito larvae enables high-throughput screening for novel larvicides and offers potential for smartphone-based detection of larval insecticide resistance". PLOS Neglected Tropical Diseases 15, n.º 6 (3 de junio de 2021): e0008639. http://dx.doi.org/10.1371/journal.pntd.0008639.
Texto completoRice, Christopher A., Emma V. Troth, A. Cassiopeia Russell y Dennis E. Kyle. "Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on Balamuthia mandrillaris, Naegleria fowleri, and Acanthamoeba castellanii". Pathogens 9, n.º 6 (16 de junio de 2020): 476. http://dx.doi.org/10.3390/pathogens9060476.
Texto completoShanley, Harrison T., Aya C. Taki, Joseph J. Byrne, Abdul Jabbar, Tim N. C. Wells, Kirandeep Samby, Peter R. Boag, Nghi Nguyen, Brad E. Sleebs y Robin B. Gasser. "A High-Throughput Phenotypic Screen of the ‘Pandemic Response Box’ Identifies a Quinoline Derivative with Significant Anthelmintic Activity". Pharmaceuticals 15, n.º 2 (21 de febrero de 2022): 257. http://dx.doi.org/10.3390/ph15020257.
Texto completoRollin-Pinheiro, Rodrigo, Mariana Ingrid Dutra da Silva Xisto, Yuri de Castro-Almeida, Victor Pereira Rochetti, Luana Pereira Borba-Santos, Yasmin da Silva Fontes, Antonio Ferreira-Pereira, Sonia Rozental y Eliana Barreto-Bergter. "Pandemic Response Box® library as a source of antifungal drugs against Scedosporium and Lomentospora species". PLOS ONE 18, n.º 2 (3 de febrero de 2023): e0280964. http://dx.doi.org/10.1371/journal.pone.0280964.
Texto completoRice, Christopher A., Luis Fernando Lares-Jiménez, Fernando Lares-Villa y Dennis E. Kyle. "In Vitro Screening of the Open-Source Medicines for Malaria Venture Malaria and Pathogen Boxes To Discover Novel Compounds with Activity against Balamuthia mandrillaris". Antimicrobial Agents and Chemotherapy 64, n.º 5 (18 de febrero de 2020). http://dx.doi.org/10.1128/aac.02233-19.
Texto completoVallières, Cindy y Simon V. Avery. "The Candidate Antimalarial Drug MMV665909 Causes Oxygen-Dependent mRNA Mistranslation and Synergizes with Quinoline-Derived Antimalarials". Antimicrobial Agents and Chemotherapy 61, n.º 9 (26 de junio de 2017). http://dx.doi.org/10.1128/aac.00459-17.
Texto completoKraft, Thomas E., Monique R. Heitmeier, Marina Putanko, Rachel L. Edwards, Ma Xenia G. Ilagan, Maria A. Payne, Joseph M. Autry, David D. Thomas, Audrey R. Odom y Paul W. Hruz. "A novel FRET-based screen in high-throughput format to identify inhibitors of malarial and human glucose transporters". Antimicrobial Agents and Chemotherapy, 10 de octubre de 2016, AAC.00218–16. http://dx.doi.org/10.1128/aac.00218-16.
Texto completoTadele, Markos, Solomon M. Abay, Peter Asaga, Eyasu Makonnen y Asrat Hailu. "In vitro growth inhibitory activity of Medicines for Malaria Venture pathogen box compounds against Leishmania aethiopica". BMC Pharmacology and Toxicology 22, n.º 1 (16 de noviembre de 2021). http://dx.doi.org/10.1186/s40360-021-00538-2.
Texto completoReader, Janette, Mariëtte E. van der Watt, Dale Taylor, Claire Le Manach, Nimisha Mittal, Sabine Ottilie, Anjo Theron et al. "Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box". Nature Communications 12, n.º 1 (11 de enero de 2021). http://dx.doi.org/10.1038/s41467-020-20629-8.
Texto completoUllah, Imran, Raman Sharma, Antonio Mete, Giancarlo A. Biagini, Dawn M. Wetzel y Paul D. Horrocks. "The relative rate of kill of the MMV Malaria Box compounds provides links to the mode of antimalarial action and highlights scaffolds of medicinal chemistry interest". Journal of Antimicrobial Chemotherapy, 29 de octubre de 2019. http://dx.doi.org/10.1093/jac/dkz443.
Texto completoDebbert, Stefan L., Mikaela J. Hintz, Christian J. Bell, Kenya R. Earl, Grant E. Forsythe, Cécile Häberli y Jennifer Keiser. "Activities of Quinoxaline, Nitroquinoxaline and [1,2,4]Triazolo[4,3-a]quinoxaline Analogs of MMV007204 against Schistosoma mansoni". Antimicrobial Agents and Chemotherapy, 30 de noviembre de 2020. http://dx.doi.org/10.1128/aac.01370-20.
Texto completoVila, Taissa y Jose L. Lopez-Ribot. "Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors". Antimicrobial Agents and Chemotherapy 61, n.º 1 (24 de octubre de 2016). http://dx.doi.org/10.1128/aac.02006-16.
Texto completoTong, Jie Xin, Rajesh Chandramohanadas y Kevin Shyong-Wei Tan. "High-Content Screening of the Medicines for Malaria Venture Pathogen Box forPlasmodium falciparumDigestive Vacuole-Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery". Antimicrobial Agents and Chemotherapy 62, n.º 3 (8 de enero de 2018). http://dx.doi.org/10.1128/aac.02031-17.
Texto completoAhyong, Vida, Christine M. Sheridan, Kristoffer E. Leon, Jessica N. Witchley, Jonathan Diep y Joseph L. DeRisi. "Identification of Plasmodium falciparum specific translation inhibitors from the MMV Malaria Box using a high throughput in vitro translation screen". Malaria Journal 15, n.º 1 (17 de marzo de 2016). http://dx.doi.org/10.1186/s12936-016-1231-8.
Texto completoSpalenka, Jérémy, Sandie Escotte-Binet, Ali Bakiri, Jane Hubert, Jean-Hugues Renault, Frédéric Velard, Simon Duchateau, Dominique Aubert, Antoine Huguenin y Isabelle Villena. "Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box". Antimicrobial Agents and Chemotherapy 62, n.º 2 (13 de noviembre de 2017). http://dx.doi.org/10.1128/aac.01640-17.
Texto completoMaccesi, Martina, Pedro H. N. Aguiar, Valérian Pasche, Melody Padilla, Brian M. Suzuki, Sandro Montefusco, Ruben Abagyan, Jennifer Keiser, Marina M. Mourão y Conor R. Caffrey. "Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery". Parasites & Vectors 12, n.º 1 (22 de octubre de 2019). http://dx.doi.org/10.1186/s13071-019-3747-6.
Texto completoNick, Marina, Frederick A. Partridge, Ruth Forman, Carole J. R. Bataille, Kathryn J. Else, Angela J. Russell y David B. Sattelle. "Screening the Medicines for Malaria Venture (MMV) Pandemic Response Box chemical library on Caenorhabditis elegans identifies re-profiled candidate anthelmintic drug leads". Frontiers in Tropical Diseases 3 (13 de octubre de 2022). http://dx.doi.org/10.3389/fitd.2022.1017900.
Texto completoVillares, Marie, Nelly Lourenço, Jeremy Berthelet, Suzanne Lamotte, Leslie Regad, Souhila Medjkane, Eric Prina, Fernando Rodrigues-Lima, Gerald F. Späth y Jonathan B. Weitzman. "Trifloxystrobin blocks the growth of Theileria parasites and is a promising drug to treat Buparvaquone resistance". Communications Biology 5, n.º 1 (15 de noviembre de 2022). http://dx.doi.org/10.1038/s42003-022-03981-x.
Texto completoCoimbra, Laís D., Alexandre Borin, Marina Fontoura, Humberto D. Gravina, Alice Nagai, Jacqueline Farinha Shimizu, Karina Bispo-dos-Santos et al. "Identification of Compounds With Antiviral Activity Against SARS-CoV-2 in the MMV Pathogen Box Using a Phenotypic High-Throughput Screening Assay". Frontiers in Virology 2 (14 de abril de 2022). http://dx.doi.org/10.3389/fviro.2022.854363.
Texto completo